The Cyprus Institute of Neurology and Genetics (CING) has acquired an advanced spatial transcriptomics platform for biological tissue analysis, according to an announcement released this week.
The institute said that this represents “ a major step forward in the field of precision medicine ” for Cyprus, adding that “this development marks a decisive advancement” for its research community.
Specifically, the Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology at CING
